Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting

详细信息    查看全文

• 作者：Melissa L James ; George Dehn and Bridget A Robinson
• 刊名：Asia-Pacific Journal of Clinical Oncology
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：12
• 期：3
• 页码：248-253
• 全文大小：103K
• ISSN：1743-7563

文摘

High-quality evidence supports that hypofractionated radiation treatment (HFRT) is as effective and safe in early breast cancer as conventionally fractionated radiation treatment. HFRT with fewer treatments has potential benefits for both patients and radiation departments. Despite this, concerns about local control and toxicity with HFRT persist, such that many eligible patients do not receive HFRT. The local recurrence rates and acute toxicity after HFRT was analyzed in our center in Christchurch, New Zealand.